Pantoprazole does not affect cyclosporin A blood concentration in kidney-transplant patients

European Journal of Clinical Pharmacology

Volumn 55, Issue 10, 2000, Pages 733-735

  Lorf, T ^a   Ramadori, G ^a   Ringe, B ^a   Schworer H ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Cyclosporin A; Pantoprazole; Proton pump inhibitors

Indexed keywords

CLARITHROMYCIN; CYCLOSPORIN A; CYTOCHROME P450 3A4; FUROSEMIDE; METOPROLOL; METRONIDAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OFLOXACIN; PANTOPRAZOLE; PREDNISOLONE; SANDIMMUN OPTORAL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG SAFETY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PEPTIC ULCER; PRIORITY JOURNAL;

EID: 0013642726     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050006     Document Type: Article

References (16)

1. 1. Rethel R, Kösters W, Linder MM, Poll M, Schwarzbeck A, Walker G (1979) Zur Prophylaxe gastroduodenaler Komplikationen nach Nierentransplantation. Med Klin 74: 1855-1860
2. 2. Timoney AG, Man WK, Spencer J, Taylor H, Williams G (1989) Histamine and duodenal ulceration in renal transplant recipients. Gut 30: 65-71
3. 3. Tryba M, Cook D (1997) Current guidelines on stress ulcer prophylaxis. Drugs 54: 581-596
4. 4. Campana C, Regazzi MB, Buggia I, Molinaro M (1996) Clinically significant drug interactions with cyclosporin. Clin Pharmacokinet 30: 141-179
5. 5. Zech K, Steinijans VW, Huber R, Kolassa N, Radtke HW (1996) Pharmacokinetics and drug interactions-relevant factors for the choice of a drug. Int J Clin Pharmacol Ther 34[suppl 1]: S3-S6
6. 6. Andersson T (1996) Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole. Clin Pharmacokinet 34: 9-28
7. 7. Reichenspurner H, Meiser BM, Muschiol F, Nollert G, Uberfuhr P, Markewitz A, Wagner F, Pfeiffer M, Reichart B (1993) The influence of gastrointestinal agents on resorption and metabolism of cyclosporine after heart transplantation: Experimental and clinical results. J Heart Lung Transplant 12: 987-992
8. 8. Schouler L, Dumas F, Couzigou P, Janvier G, Winnock S, Saric J (1991) Omeprazole-cyclosporin interaction. Am J Gastroenterol 86: 1097
9. 9. Arranz R, Yanez E, Franceschi JL, Fernandez-Ranada JM (1993) More about omeprazole-cyclosporine interaction. Am J Gastroenterol 88: 154-155
10. 10. Blohme I, Idstrom JP, Andersson T (1993) A study of the interaction between omeprazole and cyclosporine in renal transplant patients. Br J Clin Pharmacol 35: 156-160
11. 11. Steinijans VW, Huber R, Hartmann M, Zech K, Bliesath H, Wurst W, Radtke HW (1996) Lack of pantoprazole drug interactions in man: An updated review. Int J Clin Pharmacol Ther 34: 243-262
12. 12. Bliesath H, Huber R, Steinijans VW, Koch HJ, Kunz K, Wurst W (1996) Pantoprazole does not interact with nifedipine in man under steady-state conditions. Int J Clin Pharmacol Ther 34: 51-55
13. 13. Middle MV, Müller FO, Schall R, Hundt HKL, Mogilnicka EM, Beneke PC (1995) Effect of pantoprazole on ovulation suppression by a low-dose hormonal contraceptive. Clin Drug Invest 9: 54-56
14. 14. Huber R, Bliesath H, Hartmann M, Steinijans VW, Koch H, Mascher H, Wurst W (1998) Pantoprazole does not interact with the pharmacokinetics of carbamazepine. Int J Clin Pharmacol Ther 36: 521-524
15. 15. Reill L, Erhardt F, Fischer R, Rost KL, Roots J, Londong W (1993) Effect of oral pantoprazole on 24h-intragastric pH, serum gastrin profile and drug metabolizing enzyme activity in man - a placebo-controlled comparison with ranitidine. Gut 34[suppl 4]: S63
16. 16. Fitton A, Wiseman L (1996) Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders. Drugs 51: 460-482